Treatment of metastatic renal cancer with high-dose interleukin-2 after targeted therapy.

被引：0
|
作者：
Hawkins, Robert E.
Galvis, Victoria
Shanks, Jonathan
Dalal, Neha
Thistlethwaite, Fiona
Spencer-Shaw, Andrea
机构：
[1] Christie Canc Res UK, Manchester, Lancs, England
[2] Christie, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.439
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
439
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma
    Clark, James M.
    Kelley, Benjamin
    Titze, Jill
    Fung, Henry
    Maciejewski, John
    Nathan, Sunita
    Rich, Elizabeth
    Basu, Sanjib
    Kaufman, Howard L.
    ONCOLOGY, 2013, 84 (02) : 123 - 126
  • [42] Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma
    Merriman, Joseph
    Tward, Jonathan
    Albertson, Dan
    Dechet, Christopher
    Agarwal, Neeraj
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (02) : 101 - 103
  • [43] EOSINOPHILIC MYOCARDITIS ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    SCHUCHTER, LM
    HENDRICKS, CB
    HOLLAND, KH
    SHELTON, BK
    HUTCHINS, GM
    BAUGHMAN, KL
    ETTINGER, DS
    AMERICAN JOURNAL OF MEDICINE, 1990, 88 (04): : 439 - 440
  • [44] Successful treatment of cutaneous metastatic melanoma with high-dose intralesional interleukin-2 treatment combined with cryosurgery
    Martinez-Lopez, Antonio
    Manuel Almazan-Fernandez, Francisco
    Perez-Lopez, Israel
    Aguayo-Carreras, Paula
    Salvador-Rodriguez, Luis
    Cuenca-Barrales, Carlos
    Arias-Santiago, Salvador
    DERMATOLOGIC THERAPY, 2018, 31 (04)
  • [45] High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy
    Buzaid, Antonio Carlos
    Schmerling, Rafael Aron
    Vieira Guedes, Rodrigo Antonio
    de Freitas, Daniela
    William, William Nassib, Jr.
    MELANOMA RESEARCH, 2011, 21 (04) : 370 - 375
  • [46] Salvage-Targeted Kidney Cancer Therapy in Patients Progressing on High-Dose Interleukin-2 Immunotherapy The UCLA Experience
    Birkhaeuser, Frederic D.
    Pantuck, Allan J.
    Rampersaud, Edward N.
    Wang, Xiaoyan
    Kroeger, Nils
    Pouliot, Frederic
    Zomorodian, Nazy
    Riss, Joseph
    Li, Gang
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    CANCER JOURNAL, 2013, 19 (03): : 189 - 196
  • [47] Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer
    J. Y. Douillard
    J. Bennouna
    F. Vavasseur
    R. Deporte-Fety
    P. Thomare
    F. Giacalone
    K. Meflah
    Cancer Immunology, Immunotherapy, 2000, 49 : 56 - 61
  • [48] Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer
    Douillard, JY
    Bennouna, J
    Vavasseur, F
    Deporte-Fety, R
    Thomare, P
    Giacalone, F
    Meflah, K
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (01) : 56 - 61
  • [49] High-dose continuous infusion plus pulse interleukin-2 and famotidine in metastatic kidney cancer
    Quan, W
    Ramirez, M
    Taylor, C
    Vinogradov, M
    Quan, F
    Khan, N
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2005, 20 (01) : 36 - 40
  • [50] Carbonic Anhydrase IX Expression Is Associated with Improved Outcome of High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma
    Dudek, Arkadiusz Z.
    Yee, Ronald T.
    Manivel, Juan C.
    Isaksson, Rachel
    Yee, Heidi O.
    ANTICANCER RESEARCH, 2010, 30 (03) : 987 - 992
12345